Multi-gene panel testing for hereditary cancer susceptibility: A new paradigm

Article Type
Changed
Tue, 05/21/2019 - 12:16
Display Headline
Multi-gene panel testing for hereditary cancer susceptibility: A new paradigm

Click here to download the PDF.

EXECUTIVE SUMMARY

This article addresses the importance of hereditary cancer panel testing. No longer are single syndrome tests the best diagnostic for hereditary cancer risk. Panel testing addresses multiple genes that are associated with a single cancer, as well as single genes that implicate multiple cancers.

To optimize patient care, it is important to determine who is the best candidate within a family to test, and identify laboratories with the greatest accuracy in results.

Sponsor
This supplement is sponsored by Myriad Genetic Laboratories.
Article PDF
Author and Disclosure Information

Richard P. Frieder, MD
Medical Director, Intelegene
Assistant Clinical Professor
Department of Obstetrics and Gynecology
David Geffen School of Medicine
University of California, Los Angeles

Dr. Frieder reports that he is a consultant and speaker for Myriad Genetics Laboratories.

Publications
Legacy Keywords
Richard P. Frieder, MD
Medical Director, Intelegene
Assistant Clinical Professor
Sections
Author and Disclosure Information

Richard P. Frieder, MD
Medical Director, Intelegene
Assistant Clinical Professor
Department of Obstetrics and Gynecology
David Geffen School of Medicine
University of California, Los Angeles

Dr. Frieder reports that he is a consultant and speaker for Myriad Genetics Laboratories.

Author and Disclosure Information

Richard P. Frieder, MD
Medical Director, Intelegene
Assistant Clinical Professor
Department of Obstetrics and Gynecology
David Geffen School of Medicine
University of California, Los Angeles

Dr. Frieder reports that he is a consultant and speaker for Myriad Genetics Laboratories.

Article PDF
Article PDF
Related Articles
Sponsor
This supplement is sponsored by Myriad Genetic Laboratories.
Sponsor
This supplement is sponsored by Myriad Genetic Laboratories.

Click here to download the PDF.

EXECUTIVE SUMMARY

This article addresses the importance of hereditary cancer panel testing. No longer are single syndrome tests the best diagnostic for hereditary cancer risk. Panel testing addresses multiple genes that are associated with a single cancer, as well as single genes that implicate multiple cancers.

To optimize patient care, it is important to determine who is the best candidate within a family to test, and identify laboratories with the greatest accuracy in results.

Click here to download the PDF.

EXECUTIVE SUMMARY

This article addresses the importance of hereditary cancer panel testing. No longer are single syndrome tests the best diagnostic for hereditary cancer risk. Panel testing addresses multiple genes that are associated with a single cancer, as well as single genes that implicate multiple cancers.

To optimize patient care, it is important to determine who is the best candidate within a family to test, and identify laboratories with the greatest accuracy in results.

Publications
Publications
Article Type
Display Headline
Multi-gene panel testing for hereditary cancer susceptibility: A new paradigm
Display Headline
Multi-gene panel testing for hereditary cancer susceptibility: A new paradigm
Legacy Keywords
Richard P. Frieder, MD
Medical Director, Intelegene
Assistant Clinical Professor
Legacy Keywords
Richard P. Frieder, MD
Medical Director, Intelegene
Assistant Clinical Professor
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media